156 related articles for article (PubMed ID: 34328657)
1. Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44.
Liu W; Ji Z; Wu B; Huang S; Chen Q; Chen X; Wei Y; Jiang J
FEBS Lett; 2021 Sep; 595(17):2290-2302. PubMed ID: 34328657
[TBL] [Abstract][Full Text] [Related]
2. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.
Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z
Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922
[TBL] [Abstract][Full Text] [Related]
3. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
4. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
[TBL] [Abstract][Full Text] [Related]
5. Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21.
Li J; Ren H; Wang J; Zhang P; Shi X
Aging (Albany NY); 2021 Mar; 13(6):8380-8395. PubMed ID: 33661757
[TBL] [Abstract][Full Text] [Related]
6. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.
Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J
Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
Ren X; Ji Y; Jiang X; Qi X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
[TBL] [Abstract][Full Text] [Related]
8. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402.
Ma L; Pan Q; Sun F; Yu Y; Wang J
Biochem Biophys Res Commun; 2014 Aug; 451(2):334-8. PubMed ID: 25094049
[TBL] [Abstract][Full Text] [Related]
9. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
10. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
[TBL] [Abstract][Full Text] [Related]
11. N-glycosylation at N57/100/110 affects CD44s localization, function and stability in hepatocellular carcinoma.
Cheng Q; Hu X; Zhang X; Yang D; Zhao G; Sun L; Jiang M; Yang L; Cai J; Wang B; Zhang M; Han F; Li Y; Nie H
Eur J Cell Biol; 2023 Dec; 102(4):151360. PubMed ID: 37703748
[TBL] [Abstract][Full Text] [Related]
12. Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma.
Tovuu LO; Imura S; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Mori H; Hanaoka J; Kanamoto M; Sugimoto K; Iwahashi S; Saito Y; Yamada S; Asanoma M; Miyake H; Shimada M
Int J Clin Oncol; 2013 Aug; 18(4):651-6. PubMed ID: 22706704
[TBL] [Abstract][Full Text] [Related]
13. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
14. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
[TBL] [Abstract][Full Text] [Related]
15. NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44.
Koyama S; Tsuchiya H; Amisaki M; Sakaguchi H; Honjo S; Fujiwara Y; Shiota G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168951
[TBL] [Abstract][Full Text] [Related]
16. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
[TBL] [Abstract][Full Text] [Related]
17. [The regulation of CD44 expression by new tumor suppressor gene Arid2 and the influence of Arid2 on the invasion and metastasis in hepatocellular carcinoma cells].
Tian L; Duan YJ; Nie LZ; Li Z; Chen Z; Gao QZ; Yang Y; Tang N; Zheng J
Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):196-201. PubMed ID: 27095763
[TBL] [Abstract][Full Text] [Related]
18. N-glycosylation of Siglec-15 decreases its lysosome-dependent degradation and promotes its transportation to the cell membrane.
Chen X; Dang X; Song J; Wang G; Liu C; Cui L; Huang Z
Biochem Biophys Res Commun; 2020 Nov; 533(1):77-82. PubMed ID: 32921411
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts.
Yang Z; Qin W; Chen Y; Yuan B; Song X; Wang B; Shen F; Fu J; Wang H
Cancer Lett; 2018 Aug; 429():66-77. PubMed ID: 29746928
[TBL] [Abstract][Full Text] [Related]
20. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
